Summit Trail Advisors, LLC Galectin Therapeutics Inc Put Options Transaction History
Summit Trail Advisors, LLC
- $3.71 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GALT
# of Institutions
65Shares Held
7.62MCall Options Held
61.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.98MShares$4.47 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.26MShares$2.86 Million0.01% of portfolio
-
Black Rock Inc. New York, NY713KShares$1.61 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA567KShares$1.28 Million0.0% of portfolio
-
Geneos Wealth Management Inc.409KShares$924,0000.05% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $134M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...